Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
Scarpa
C
C
Department of Dermatology, Trieste University, Italy.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005938:Glucocorticoids; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D012459:Salicylates / Q000008:administration & dosage*; D020156:Salicylic Acid
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids; D012459:Salicylates; C055085:calcipotriene; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D002117:Calcitriol; D020156:Salicylic Acid